We are live on ! Find out more
LVACU

LAVA Medtech Acquisition Corp. Unit
LVACU

Delisted

LVACU was delisted on the 19th of April, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in LAVA Medtech Acquisition Corp. Unit in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $703K → $0 (-$703K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
–
Holders Change
-4
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
SIA
Schechter Investment Advisors
Michigan
-$373K
2
Walleye Capital
Walleye Capital
New York
-$315K
3
CS
Clear Street
New York
-$12K
4
GCL
Glazer Capital LLC
New York
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
SIA
1
Schechter Investment Advisors
Michigan
– -$373K -37,000 Closed
Walleye Capital
2
Walleye Capital
New York
– -$315K -30,226 Closed
CS
3
Clear Street
New York
– -$12K -1,150 Closed
GCL
4
Glazer Capital LLC
New York
– -$3K -300 Closed

LVACU Hedge Fund Activity: Q2 2023 in Review

0 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Unit (LVACU) for Q2 2023, worth a combined $0 — down 100% from $703K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of LVACU and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Schechter Investment Advisors, exiting entirely with an estimated $373K sold.

  • 0 institutional investors held LAVA Medtech Acquisition Corp. Unit (LVACU) as of Q2 2023, down from 4 in Q1 2023.
  • Funds reported $0 of LAVA Medtech Acquisition Corp. Unit stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new LAVA Medtech Acquisition Corp. Unit positions in Q2 2023 and 4 closed out, a net change of -4 holders.
  • The largest LAVA Medtech Acquisition Corp. Unit seller in Q2 2023 was Schechter Investment Advisors, an estimated $373K sold.

Based on aggregated 13F filings for Q2 2023.